Using the Clinical Proteomic Tumor Analysis Consortium (CPTAC) analysis, significantly elevated levels of TPX2 phosphorylation at S738 were identified in primary BRCA compared to control tissues. This evidence concerns the gene TPX2 and neoplasm.